Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.42 BRL | +19.48% |
|
+0.64% | +54.35% |
07:12pm | WHO Issues First Medical Product Notice Amid Reports of Counterfeit Batches of Novo Nordisk's Ozempic | MT |
04:28pm | WHO issues warnings on falsified diabetes and weight-loss drugs | RE |
Sales 2024 * | 29TCr 4.18TCr 23TCr 3,49400Cr | Sales 2025 * | 35TCr 5.05TCr 28TCr 4,22000Cr | Capitalization | 4,42600Cr 64TCr 3,46100Cr 53,10400Cr |
---|---|---|---|---|---|
Net income 2024 * | 10TCr 1.5TCr 8.18TCr 1,25600Cr | Net income 2025 * | 13TCr 1.83TCr 9.98TCr 1,53200Cr | EV / Sales 2024 * | 15.3 x |
Net Debt 2024 * | 2.21TCr 316.96Cr 1.73TCr 26TCr | Net cash position 2025 * | 603.53Cr 87Cr 471.87Cr 7.24TCr | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
42.2
x | P/E ratio 2025 * |
34.5
x | Employees | 66,015 |
Yield 2024 * |
1.2% | Yield 2025 * |
1.47% | Free-Float | 70.17% |
Latest transcript on Novo Nordisk A/S
1 day | +19.48% | ||
1 week | +0.64% | ||
Current month | +7.13% | ||
1 month | +14.26% | ||
3 months | +18.61% | ||
6 months | +54.15% | ||
Current year | +54.35% |
![Extreme 92.08](/images/extremecours_fleche.png)
![Extreme 83](/images/extremecours_fleche.png)
![Extreme 61.74](/images/extremecours_fleche.png)
![Extreme 45.59](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01/91/01 | |
Director of Finance/CFO | 53 | 01/99/01 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 62 | 19/15/19 |
Helge Lund
CHM | Chairman | 61 | 23/17/23 |
Martin MacKay
BRD | Director/Board Member | 68 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
21/24/21 | 96.42 | +19.48% | 7 605 |
19/24/19 | 94.53 | -1.06% | 2,502 |
18/24/18 | 95.54 | +0.22% | 3,441 |
17/24/17 | 95.33 | -0.01% | 3,999 |
14/24/14 | 95.34 | -0.49% | 17,140 |
Delayed Quote Sao Paulo, June 21, 2024 at 01:22 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.99% | 80TCr | |
-5.72% | 35TCr | |
+18.94% | 32TCr | |
+11.07% | 30TCr | |
+16.96% | 24TCr | |
+2.25% | 23TCr | |
+11.15% | 22TCr | |
+7.59% | 16TCr | |
-3.65% | 16TCr |
- Stock Market
- Equities
- NOVO B Stock
- N1VO34 Stock